Skip to main content
. 2023 May 30;25(2):272–281. doi: 10.5853/jos.2022.03370

Table 1.

Baseline characteristics of all patients included in the primary analyses

Characteristic EVT (n=222) IVT (n=68) P OR (95% CI)
Demographics
Age (yr), median (IQR) 53 (46–60) 49 (40–58) 0.127 -
Female sex 52/222 (23.4) 20/68 (29.4) 0.317 0.73 (0.40–1.35)
Medical history
Atrial fibrillation 8/221 (3.6) 1/68 (1.5) 0.691 2.52 (0.31–20.49)
Hypertension 74/222 (33.3) 22/68 (32.4) 0.881 1.05 (0.59–1.87)
Current smoking (or stopped less than 2 years ago) 64/218 (29.4) 13/68 (19.1) 0.096 1.76 (0.89–3.44)
Hypercholesterolemia 60/222 (27.0) 18/68 (26.5) 0.928 1.03 (0.56–1.90)
Diabetes mellitus 8/222 (3.6) 5/68 (7.4) 0.192 0.47 (0.15–1.49)
Coronary artery disease 8/222 (3.6) 4/68 (5.9) 0.485 0.59 (0.17–2.05)
Prior stroke (ischemic or hemorrhagic) 20/217 (9.2) 9/68 (13.2) 0.339 0.67 (0.29–1.54)
Pre-stroke independency (pre-stroke mRS 0–2) 215/218 (98.6) 67/68 (98.5) 0.954 1.07 (0.11–10.46)

Data are presented as n (%) unless otherwise indicated.

EVT, endovascular treatment; IVT, intravenous thrombolysis; OR, odds ratio; CI, confidence interval; IQR, interquartile range; mRS, modified Rankin Scale.